| Product Name | MF | CAS | Details |
|---|
| H-VV-OH | Details |
| Phenyl 2,3,4-tri-O-benzyl-b-L-thiofucopyranose | C33H34O4S | 167612-35-3 | Details |
| 5-O-[(1,1-Dimethylethyl)diphenylsilyl]-1,2-O-(1-methylethylidene)-β-D-lyxofuranose | C24H32O5Si | 133048-89-2 | Details |
| 5-Isopropyl-1,3-cyclohexanedione | C9H14O2 | 18456-87-6 | Details |
| 4-Bromo-1,3-dioxaindane-5-carbaldehyde | C8H5BrO3 | 56008-63-0 | Details |
| Koenimbine | C19H19NO2 | 21087-98-9 | Details |
| H-YPLHEQHGM-OH | Details |
| Garjasmin | C11H12O5 | 144868-43-9 | Details |
| 2-Bromo-4-chlorobenzoic acid methyl ester | C8H6BrClO2 | 57381-62-1 | Details |
| trans-2-[4-(Oxan-2-yloxy)phenyl]cyclopropane-1-carboxylic acid | C15H18O4 | 1946017-75-9 | Details |
| LGALS1 antibody | Details |
| 2-(1H-1,2,4-Triazol-1-yl)acetic acid hydrochloride | C4H6ClN3O2 | 113534-57-9 | Details |
| 4-Oxatricyclo[4.2.1.0,3,7]nonane-2,5-dione | C8H8O3 | 16479-73-5 | Details |
| Pyridine-2-carboxamidine | C6H7N3 | 52313-50-5 | Details |
| {1-Oxaspiro[4.7]dodecan-2-yl}methanol | 1864550-40-2 | Details |
| (1,2-Dibromoethyl)benzene | C8H8Br2 | 93-52-7 | Details |
| IGF2 antibody | Details |
| H-VMAPRTVLL-OH | Details |
| 2-(Bromomethyl)-4-chloro-1-(cyclopropylmethoxy)benzene | C11H12BrClO | 1103261-00-2 | Details |
| 2-Bromo-2',4'-dichloroacetophenone | C8H5BrCl2O | 2631-72-3 | Details |
| 4-Bromo-3-fluorobenzylamine hydrochloride | C7H8BrClFN | 1214342-53-6 | Details |
| 3-(2-Methoxyethyl)-2-sulfanylidene-2H,3H,4H,8H-pyrido[2,3-d]pyrimidin-4-one | 688793-17-1 | Details |
| 2,3,4,5-Tetrahydro-1H-1-benzazepin-5-ol | C10H13NO | 54620-79-0 | Details |
| H-Gln-Gln-OH | C10H18N4O5 | 54419-93-1 | Details |
| 5-Hydroxy imazapyr | C13H15N3O4 | 102771-62-0 | Details |
| 3-Iodo-2,6-dimethoxypyridine | C7H8INO2 | 214360-56-2 | Details |
| 1,1-Diethoxy-2-methanesulfinylethane | C7H16O3S | 1344048-22-1 | Details |
| 3-(2,2-Difluoro-1,3-dioxaindan-5-yl)propanoic acid | C10H8F2O4 | 1519455-25-4 | Details |
| LG 100268 | C24H29NO2 | 153559-76-3 | Details |
| Anti-FCGR3B antibody R2G - 0.5mg/mL | Details |
| (+)-9-Hydroxyrisperidone | C23H27FN4O3 | 130049-85-3 | Details |
| 2-(Methylamino)benzene-1,4-diol hydrobromide | C7H10BrNO2 | 32190-96-8 | Details |
| 7-Bromo-3-O-acetyl pregnenolone | C23H33BrO3 | 114417-65-1 | Details |
| RG3039 | C21H23Cl2N5O | 1005504-62-0 | Details |
| 2-Ethoxy-3,4-dihydro-2H-pyran | C7H12O2 | 103-75-3 | Details |
| N-[4,5-Bis(4-tert-butylphenyl)-3-cyanofuran-2-yl]-2-chloroacetamide | C27H29ClN2O2 | 721415-84-5 | Details |
| Ethyl 1-(1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)piperidine-4-carboxylate | C14H19N5O2 | 681428-42-2 | Details |
| 1-[(3-Methyl-1,2,4-oxadiazol-5-yl)methyl]-1H-pyrazole-4-carboxylic acid | C8H8N4O3 | 1155064-95-1 | Details |
| Butyrolactone V | C24H24O8 | 1151509-01-1 | Details |
| 4,4-Dimethyl-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid | C13H16O2 | 78103-80-7 | Details |
| 3-Chloro-5-[(4-chlorophenyl)methanesulfinyl]-1,2,4-thiadiazole | C9H6Cl2N2OS2 | 486997-65-3 | Details |
| L-Cysteinyl-L-lysine trifluoroacetate | C9H19N3O3S | 71190-90-4 | Details |
| 2-Cyclobutoxyethane-1-sulfonamide | C6H13NO3S | 1340111-55-8 | Details |
| [5-FAM]-RPKPQQFFGLM-NH2 | Details |
| Intoplicine | C21H24N4O | 125974-72-3 | Details |
| (2S, 3R, 4R, 5S) -2- (Hydroxymethyl) - 3, 4, 5- piperidinetriol | C6H13NO4 | 16647-80-6 | Details |
| 5-(4-Bromophenyl)-1,2,4-triazine-3-thiol | C9H6BrN3S | 98592-15-5 | Details |
| N,N-Dimethyl-6-oxo-4-phenyl-1,6-dihydropyridine-3-carboxamide | C14H14N2O2 | 1909309-08-5 | Details |
| Mm 77 dihydrochloride | C19H27N3O3.2HCl | 159187-70-9 | Details |
| 2-Amino-1-(4-chlorophenyl)butan-1-ol hydrochloride | 38847-88-0 | Details |
| H-VFIPKPFR-OH | Details |
| N-Methyl 4-bromo-3-methylbenzenesulfonamide | C8H10BrNO2S | 923148-87-2 | Details |
| 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid diethyl ester | C19H22N2O6 | 21829-28-7 | Details |
| Goat anti Mouse IgG (Fab'2) | Details |
| Prepro VIP (156-170) (human) | C71H106N16O31 | 107902-86-3 | Details |
| 4-(Ethylsulfonyl)piperidine hydrochloride | C7H16ClNO2S | 1147107-63-8 | Details |
| 2-Benzoylbenzene-1-sulfonyl chloride | C13H9ClO3S | 54075-06-8 | Details |
| tert-Butyl N-(3-bromopropyl)-N-cyclopropylcarbamate | C11H20BrNO2 | 862718-33-0 | Details |
| tert-Butyl 2-methyl-3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate | C13H21NO3 | 1956335-05-9 | Details |
| ACADSB antibody | Details |
| Methyl({[5-(trifluoromethyl)-1H-1,3-benzodiazol-2-yl]methyl})amine dihydrochloride | C10H11ClF3N3 | 1632257-96-5 | Details |
| [1-(Oxan-4-yl)cyclopropyl]methanamine | C9H17NO | 1492419-35-8 | Details |
| 3,4-Dihydro-2H-1,4-benzothiazine-1,1-dione | C8H9NO2S | 82299-64-7 | Details |
| 1-(5-Aminopyridin-2-yl)-3-(methoxymethyl)-4,5-dihydro-1H-pyrazol-5-one | C10H12N4O2 | 1249072-71-6 | Details |
| N-(3-Aminopropyl)-2-chlorobenzene-1-sulfonamide hydrochloride | C9H14Cl2N2O2S | 1803611-62-2 | Details |
| (3-Acetylphenoxy)acetic acid | C10H10O4 | 1878-80-4 | Details |
| 4-Hydroxy-5-methylquinoline | C10H9NO | 848128-81-4 | Details |
| tert-Butyl 3-amino-4-cyano-1-methyl-1H-pyrrole-2-carboxylate | C11H15N3O2 | 1803581-55-6 | Details |
| 3-Amino-4,5-dimethylbenzene-1-sulfonamide | C8H12N2O2S | 101251-33-6 | Details |
| 6-Ethoxy-4,5-dihydro-2H-indazole | C9H12N2O | 73625-67-9 | Details |
| 4-[(Tetrahydro-2H-pyran-4-yl)oxy]aniline hydrochloride | C11H15NO2 | 917483-71-7 | Details |
| 2-(3-Methylbutan-2-yl)-2,3-dihydro-1H-isoindol-4-amine | C13H20N2 | 1099671-03-0 | Details |
| MAT2A Blocking Peptide | Details |
| H-KIRLRPGGKKKY-OH | Details |
| 2-(4-Amino-3-methylphenoxy)acetamide | C9H12N2O2 | 201853-03-4 | Details |
| 1-(2-Aminoethyl)-1,2-dihydropyridin-2-one dihydrochloride | C7H11ClN2O | 1384428-69-6 | Details |
| H-Cys(Acm)-2-chlorotrityl resin (200-400 mesh) (Low Substitution) | Details |
| Methyl 2-acetamido-2-deoxy-3-O-(a-D-galactopyranosyl)-a-D-galactopyranoside | Details |
| H-GILIDTSR^-OH | Details |
| anti-ASFV Monoclonal | Details |
| 4-(1,3-Thiazol-2-yloxy)phenol | C9H7NO2S | 1178500-32-7 | Details |
| Ac-RDGY-NH2 | Details |
| BRUNOL5 Blocking Peptide | Details |
| (4-Fluorophenyl)(pyridin-4-yl)methanamine | C12H11FN2 | 917746-83-9 | Details |
| 2-{1,3-Dimethyl-2,4-dioxo-1H,2H,3H,4H,7H-pyrrolo[2,3-d]pyrimidin-7-yl}acetic acid | C10H11N3O4 | 950259-70-8 | Details |
| 2-[5-(Trifluoromethyl)oxolan-2-yl]acetic acid | C7H9F3O3 | 2126178-97-8 | Details |
| PKC theta antibody (Thr538) | Details |
| 1-[1-(Cyclobutylmethyl)cyclopropyl]methanamine hydrochloride | C9H18ClN | 1779133-63-9 | Details |
| 4-Chloro-2-ethyl-7-methylthieno[3,2-d]pyrimidine | C9H9ClN2S | 1388056-60-7 | Details |
| 4-Oxo-3,4-dihydro-2H-1-benzothiopyran-6-carboxylic acid | C10H8O3S | 128121-49-3 | Details |
| GNAI1 Blocking Peptide | Details |
| Ly 456236 hydrochloride | C16H15N3O2 | 338738-57-1 | Details |
| Methyl 5-ethynyl-1-methyl-1H-pyrazole-3-carboxylate | C8H8N2O2 | 19762-23-3 | Details |
| Palmitoyl coenzyme A potassium salt | C37H67KN7O17P3S | 369657-00-1 | Details |
| 2-(4-Formylpiperazin-1-yl)pyridine-3-carbonitrile | C11H12N4O | 1225710-24-6 | Details |
| Sulfasymazine | C13H17N5O2S | 1984-94-7 | Details |
| ILF2 antibody (FITC) | Details |
| 2-[5-(Methylsulfamoyl)thiophen-2-yl]acetic acid | C7H9NO4S2 | 1040084-18-1 | Details |
| H-VTILQPSYTEDS-OH | Details |
| Product Total： Product Page： | ||||
| 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 | ||||